Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (PseudIgY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Immunsystem AB
ClinicalTrials.gov Identifier:
NCT00633191
First received: March 4, 2008
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)